Cargando…

Non-small cell lung cancer treatment (r)evolution: ten years of advances and more to come

Diagnostic and treatment algorithms in non-small cell lung cancer (NSCLC) are evolving at a never-before-seen pace. Histological subtyping to maximise treatment efficacy and avoid toxicity has marked the beginning of the revolution, opening the way to molecular characterisation to guide genomically...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toschi, Luca, Rossi, Sabrina, Finocchiaro, Giovanna, Santoro, Armando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718252/ https://www.ncbi.nlm.nih.gov/pubmed/29225694 http://dx.doi.org/10.3332/ecancer.2017.787

Ejemplares similares

Impact of Antibiotic Therapy and Metabolic Parameters in Non-Small Cell Lung Cancer Patients Receiving Checkpoint Inhibitors
por: Castello, Angelo, et al.
Publicado: (2021)

Increased SOX2 Gene Copy Number Is Associated with FGFR1 and PIK3CA Gene Gain in Non-Small Cell Lung Cancer and Predicts Improved Survival in Early Stage Disease
por: Toschi, Luca, et al.
Publicado: (2014)

Biological Cybernetics: 60 years and more to come
por: Lindner, Benjamin, et al.
Publicado: (2021)

Gemcitabine for the treatment of advanced nonsmall cell lung cancer
por: Toschi, Luca, et al.
Publicado: (2009)

Continuous evolution of HIV-1 more than ten years after infection in an elite neutralizer
por: Chaillon, A, et al.
Publicado: (2012)

A lot is done and more will come
por: Kagan, Karl Oliver
Publicado: (2022)

The coming of age of liquid biopsy in neuro-oncology
por: Berzero, Giulia, et al.
Publicado: (2023)

Advancement Comes with Responsibility
por: Chung, Min Suk
Publicado: (2019)

Ebola Conquers West Africa — More to Come?
por: Halfmann, Peter, et al.
Publicado: (2014)

Editorial: One volume down, more to come
Publicado: (2008)

Inflammatory Bowel Disease and the Environment: More to Come
por: El-Matary, Wael
Publicado: (2020)

Is more always better when it comes to mating?
por: Kokko, Hanna, et al.
Publicado: (2023)

Death comes in small packages
por: LeBrasseur, Nicole
Publicado: (2004)

After More Than 50 Years, Pharmacare (and Dental Care) are Coming to Canada
por: Lexchin, Joel
Publicado: (2022)

Comparison of Metabolic and Morphological Response Criteria for Early Prediction of Response and Survival in NSCLC Patients Treated With Anti-PD-1/PD-L1
por: Castello, Angelo, et al.
Publicado: (2020)

“Not all groups come together, but this one just clicks”: Ten Tips for Sustaining an Engagement Panel
por: Jensen, Agnes C., et al.
Publicado: (2022)

Interesting things come in small packages
por: DeLong, Edward F
Publicado: (2010)

Where did the super-small sized large bowel advanced cancer come from?
por: Wada, Ryo, et al.
Publicado: (2007)

BCL2: a 30-year tale of life, death and much more to come
por: Pentimalli, Francesca
Publicado: (2018)

A decade of marketing analytics and more to come: JMA insights
por: Petrescu, Maria, et al.
Publicado: (2023)

Ten years of biosimilars in Europe: development and evolution of the regulatory pathways
por: Schiestl, Martin, et al.
Publicado: (2017)

Genetic testing for channelopathies, more than ten years progress and remaining challenges
por: Zhou, Peng, et al.
Publicado: (2010)

Ten-year experience of more than 35,000 orofacial clefts in Africa
por: Conway, Julia C, et al.
Publicado: (2015)

In the Company of Microbes: Ten Years of Small Things Considered
por: Danila, Richard
Publicado: (2018)

HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients
por: Cappuzzo, F, et al.
Publicado: (2005)

Ten simple rules for more objective decision-making
por: Fletcher, Anthony C., et al.
Publicado: (2020)

Radiosurgery for Patients with More Than Ten Brain Metastases
por: Kida, Yoshihisa, et al.
Publicado: (2020)

Renal Function, Adherence and Quality of Life Improvement After Conversion From Immediate to Prolonged-Release Tacrolimus in Liver Transplantation: Prospective Ten-Year Follow-Up Study
por: Toti, Luca, et al.
Publicado: (2022)

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer
por: Landi, Lorenza, et al.
Publicado: (2019)

Spectres of Clock Evolution: Past, Present, and Yet to Come
por: Jabbur, Maria Luísa, et al.
Publicado: (2022)

Large volume unresectable locally advanced non-small cell lung cancer: acute toxicity and initial outcome results with rapid arc
por: Scorsetti, Marta, et al.
Publicado: (2010)

Soluble PD-L1 in NSCLC Patients Treated with Checkpoint Inhibitors and Its Correlation with Metabolic Parameters
por: Castello, Angelo, et al.
Publicado: (2020)

Twenty Years, and More to Come: Learning What Makes Some Transplants Ultra-Long Survivors
por: Maggiore, Umberto
Publicado: (2022)

Dose escalation in the era of ablative lung irradiation: is more dose better when it comes to delivery of lung stereotactic body radiation therapy?
por: Alite, Fiori, et al.
Publicado: (2020)

Do general practitioners prescribe more antimicrobials when the weekend comes?
por: Tandan, Meera, et al.
Publicado: (2015)

Knowing What’s Coming: Unpredictable Motion Causes More Motion Sickness
por: Kuiper, Ouren X., et al.
Publicado: (2019)

Neonates Have a Lot More at Stake When It Comes to Infections
por: Jain, Lucky
Publicado: (2021)

Plants and Small Molecules: An Up-and-Coming Synergy
por: Lepri, A., et al.
Publicado: (2023)

Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC)
por: Cappuzzo, F, et al.
Publicado: (2004)

Break the Mold: A Ten-Year Evolution of Ear Molding Techniques
por: Charipova, Karina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ug82ohq6q9bqj1b6cktkrc9j5b